{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:29:23Z","timestamp":1794324563849,"version":"4.9.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.clinbiochem.2020.10.011","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T15:12:28Z","timestamp":1605107548000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Detection of glucosylsphingosine in dried blood spots for diagnosis of Gaucher disease by LC-MS\/MS"],"prefix":"10.1016","volume":"87","author":[{"given":"Chengfang","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sichi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minzhi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2020.10.011_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0010","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","article-title":"Gaucher disease epidemiology and natural history: a comprehensive review of the literature","volume":"22","author":"Nalysnyk","year":"2017","journal-title":"Hematology"},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.10.011_b0020","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/jhg.2017.36","article-title":"Successful newborn screening for Gaucher disease using fluorometric assay in China","volume":"62","author":"Kang","year":"2017","journal-title":"J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.clinbiochem.2020.10.011_b0025","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1194\/jlr.R003996","article-title":"Multi-system disorders of glycosphingolipid and ganglioside metabolism","volume":"51","author":"Xu","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41598-017-18405-8","article-title":"Alterations in the properties of the cell membrane due to glycosphingolipid accumulation in a model of Gaucher disease","volume":"8","author":"Batta","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cca.2020.03.016","article-title":"High risk screening for Gaucher disease in patients with splenomegaly and\/or thrombocytopenia in China: 55 cases identified","volume":"506","author":"Huang","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcmd.2016.10.026","article-title":"Clinical and molecular characteristics of patients with Gaucher disease in Southern China","volume":"68","author":"Feng","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0045","doi-asserted-by":"crossref","first-page":"e79732","DOI":"10.1371\/journal.pone.0079732","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients","volume":"8","author":"Rolfs","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20123033","article-title":"Glucosylsphingosine (lyso-Gb1) as a biomarker for monitoring treated and untreated children with Gaucher disease","volume":"20","author":"Hurvitz","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0055","doi-asserted-by":"crossref","first-page":"E140","DOI":"10.1002\/ajh.25074","article-title":"Glucosylsphingosine is a reliable response biomarker in Gaucher disease","volume":"93","author":"Arkadir","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0060","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1515\/cclm-2019-0949","article-title":"LC-MS\/MS analysis of plasma glucosylsphingosine as a biomarker for diagnosis and follow-up monitoring in Gaucher disease in the Spanish population","volume":"58","author":"Irun","year":"2020","journal-title":"Clin. Chem. Lab Med."},{"issue":"16","key":"10.1016\/j.clinbiochem.2020.10.011_b0065","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1021\/acs.analchem.7b01442","article-title":"Glucosylceramide and glucosylsphingosine quantitation by liquid chromatography-tandem mass spectrometry to enable in vivo preclinical studies of neuronopathic gaucher disease","volume":"89","author":"Hamler","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymgme.2017.08.005","article-title":"Reductions in glucosylsphingosine (lyso-Gb1) in treatment-na\u00efve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: data from phase 3 clinical trials","volume":"122","author":"Elstein","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4235","article-title":"A HILIC-MS\/MS method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum","volume":"32","author":"Sidhu","year":"2018","journal-title":"Biomed. Chromatogr.: BMC"},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0080","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bcmd.2015.01.006","article-title":"Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard","volume":"54","author":"Mirzaian","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"1-2","key":"10.1016\/j.clinbiochem.2020.10.011_b0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymgme.2011.07.014","article-title":"The use of dried blood spot samples in the diagnosis of lysosomal storage disorders \u2014 Current status and perspectives","volume":"104","author":"Reuser","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2014.01.030","article-title":"Detecting multiple lysosomal storage diseases by tandem mass spectrometry \u2014 a national newborn screening program in Taiwan","volume":"431","author":"Liao","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.10.011_b0095","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jimd.12192","article-title":"Expanding the clinical utility of glucosylsphingosine for Gaucher disease","volume":"43","author":"Saville","year":"2020","journal-title":"J. Inher. Metab. Dis."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0100","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1515\/cclm-2018-1301","article-title":"Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study","volume":"57","author":"Polo","year":"2019","journal-title":"Clin. Chem. Lab Med."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134577","article-title":"Treatment efficiency in gaucher patients can reliably be monitored by quantification of lyso-gb1 concentrations in dried blood spots","volume":"21","author":"Cozma","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.clinbiochem.2020.10.011_b0110","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1039\/C7AN00938K","article-title":"A convenient approach to facilitate monitoring Gaucher disease progression and therapeutic response","volume":"142","author":"Zhang","year":"2017","journal-title":"Analyst"},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.10.011_b0115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ejh.12596","article-title":"A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and\/or Thrombocytopenia","volume":"96","author":"Motta","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0120","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1021\/acs.analchem.6b01190","article-title":"Hematocrit-independent quantitation of stimulants in dried blood spots: pipet versus microfluidic-based volumetric sampling coupled with automated flow-through desorption and online solid phase extraction-LC-MS\/MS bioanalysis","volume":"88","author":"Verplaetse","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.clinbiochem.2020.10.011_b0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jpba.2018.10.010","article-title":"Is the hematocrit still an issue in quantitative dried blood spot analysis?","volume":"163","author":"Velghe","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.clinbiochem.2020.10.011_b0130","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease: Glucosylsphingosine is a Key Biomarker of Gaucher Disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"Am. J. Hematol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912020308730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912020308730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:56:38Z","timestamp":1757865398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912020308730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":26,"alternative-id":["S0009912020308730"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2020.10.011","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of glucosylsphingosine in dried blood spots for diagnosis of Gaucher disease by LC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2020.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}